ERS clinical practice guidelines on treatment of sarcoidosis
Robert P. Baughman(University of Cincinnati), Daniel R. Ouellette(Henry Ford Hospital), Peter Korsten(Universitätsmedizin Göttingen), Thomy Tonia(University of Bern), Paola Rottoli(University of Siena), Ginger Spitzer(Pulmonary Fibrosis Foundation), Bernd Quadder, Francesco Bonella(Ruhrlandklinik), Marjolein Drent(Amsterdam UMC Location VUmc), David Rigau(Iberoamerican Cochrane Centre), Marc A. Judson(National Institutes of Health), Alexander G. Mathioudakis(Manchester University NHS Foundation Trust), Κατερίνα Αντωνίου(University of Crete), Dominique Valeyre(Inserm), Blin Nagavci(University of Freiburg), Wim Wuyts(KU Leuven), Athol U. Wells(Royal Brompton Hospital), Jan C. Grutters(University Medical Center Utrecht), Daniel A. Culver(Cleveland Clinic), Dominique Israël‐Biet(Assistance Publique – Hôpitaux de Paris), F Martone(Associazione Italiana Vulvodinia Onlus), Elyse E. Lower(University of Cincinnati)
Cited by 579
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k